Modeling genetic epileptic encephalopathies using brain organoids

EMBO Mol Med. 2021 Aug 9;13(8):e13610. doi: 10.15252/emmm.202013610. Epub 2021 Jul 15.

Abstract

Developmental and epileptic encephalopathies (DEE) are a group of disorders associated with intractable seizures, brain development, and functional abnormalities, and in some cases, premature death. Pathogenic human germline biallelic mutations in tumor suppressor WW domain-containing oxidoreductase (WWOX) are associated with a relatively mild autosomal recessive spinocerebellar ataxia-12 (SCAR12) and a more severe early infantile WWOX-related epileptic encephalopathy (WOREE). In this study, we generated an in vitro model for DEEs, using the devastating WOREE syndrome as a prototype, by establishing brain organoids from CRISPR-engineered human ES cells and from patient-derived iPSCs. Using these models, we discovered dramatic cellular and molecular CNS abnormalities, including neural population changes, cortical differentiation malfunctions, and Wnt pathway and DNA damage response impairment. Furthermore, we provide a proof of concept that ectopic WWOX expression could potentially rescue these phenotypes. Our findings underscore the utility of modeling childhood epileptic encephalopathies using brain organoids and their use as a unique platform to test possible therapeutic intervention strategies.

Keywords: DNA damage; SCAR12; WOREE syndrome; Wnt pathway; cerebral organoids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain
  • Brain Diseases*
  • Child
  • Humans
  • Mutation
  • Organoids
  • Spasms, Infantile*